These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8961510)

  • 21. Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting.
    Fotouhi F; Soleimanjahi H; Roostaee MH; Behzadian F
    FEMS Immunol Med Microbiol; 2008 Oct; 54(1):18-26. PubMed ID: 18647350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylactic herpes simplex virus type 2 vaccine adjuvanted with a universal CD4 T cell helper peptide induces long-term protective immunity against lethal challenge in mice.
    Li X; Zhang S; Lei J; Zhu Y; Zhou X; Xiao J; Xiang T
    Int Immunopharmacol; 2018 Aug; 61():100-108. PubMed ID: 29857239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice.
    Del Campo J; Lindqvist M; Cuello M; Bäckström M; Cabrerra O; Persson J; Perez O; Harandi AM
    Vaccine; 2010 Feb; 28(5):1193-200. PubMed ID: 19945418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of genital herpes simplex virus type 1 and 2 disease in mice immunized with a gD-expressing dominant-negative recombinant HSV-1.
    Brans R; Akhrameyeva NV; Yao F
    J Invest Dermatol; 2009 Oct; 129(10):2470-9. PubMed ID: 19357711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A vaccinia virus--herpes simplex virus (HSV) glycoprotein B1 recombinant or an HSV vaccine overcome the HSV type 2 induced humoral immunosuppression and protect against vaginal challenge in BALB/c mice.
    Fleck M; Podlech J; Weise K; Falke D
    Med Microbiol Immunol; 1994 May; 183(2):87-94. PubMed ID: 7935163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective immune correlates can segregate by vaccine type in a murine herpes model system.
    Sin JI; Ayyavoo V; Boyer J; Kim J; Ciccarelli RB; Weiner DB
    Int Immunol; 1999 Nov; 11(11):1763-73. PubMed ID: 10545480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue.
    Gillgrass AE; Tang VA; Towarnicki KM; Rosenthal KL; Kaushic C
    J Virol; 2005 Mar; 79(5):3117-26. PubMed ID: 15709031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease.
    McClements WL; Armstrong ME; Keys RD; Liu MA
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11414-20. PubMed ID: 8876149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with combined HSV-2 glycoproteins B2 : D2 gene DNAs: protection against lethal intravaginal challenges in mice.
    Lee HH; Cha SC; Jang DJ; Lee JK; Choo DW; Kim YS; Uh HS; Kim SY
    Virus Genes; 2002 Oct; 25(2):179-88. PubMed ID: 12416680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
    Da Costa XJ; Morrison LA; Knipe DM
    Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent Herpes simplex virus-2 induced disease in mice.
    Fló J; Tisminetzky S; Baralle F
    Vaccine; 2001 Feb; 19(13-14):1772-82. PubMed ID: 11166903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of the immune response to DNA vaccine by co-delivery of costimulatory molecules.
    Fló J; Tisminetzky S; Baralle F
    Immunology; 2000 Jun; 100(2):259-67. PubMed ID: 10886404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity and efficacy of intramuscular replication-defective and subunit vaccines against herpes simplex virus type 2 in the mouse genital model.
    Delagrave S; Hernandez H; Zhou C; Hamberger JF; Mundle ST; Catalan J; Baloglu S; Anderson SF; DiNapoli JM; Londoño-Hayes P; Parrington M; Almond J; Kleanthous H
    PLoS One; 2012; 7(10):e46714. PubMed ID: 23071620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes.
    Macmillan L; Ifere GO; He Q; Igietseme JU; Kellar KL; Okenu DM; Eko FO
    FEMS Immunol Med Microbiol; 2007 Feb; 49(1):46-55. PubMed ID: 17094789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model.
    Sin JI; Kim JJ; Boyer JD; Ciccarelli RB; Higgins TJ; Weiner DB
    J Virol; 1999 Jan; 73(1):501-9. PubMed ID: 9847356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA immunization with a herpes simplex virus 2 bacterial artificial chromosome.
    Meseda CA; Schmeisser F; Pedersen R; Woerner A; Weir JP
    Virology; 2004 Jan; 318(1):420-8. PubMed ID: 14972567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Construction and Immunogenicity Analysis of Herpes Simplex Virus Type 2 Glycoprotein D Recombinant Adenovirus Vaccine].
    Liu W; Zhao D; Wang Z; Li Y; Wang H; Wang H
    Bing Du Xue Bao; 2016 May; 32(3):267-72. PubMed ID: 29962197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge.
    Sin JI; Kim JJ; Arnold RL; Shroff KE; McCallus D; Pachuk C; McElhiney SP; Wolf MW; Pompa-de Bruin SJ; Higgins TJ; Ciccarelli RB; Weiner DB
    J Immunol; 1999 Mar; 162(5):2912-21. PubMed ID: 10072541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of intramuscular and footpad subcutaneous immunization with DNA vaccine encoding HSV-gD2 in mice.
    Jazayeri M; Soleimanjahi H; Fotouhi F; Pakravan N
    Comp Immunol Microbiol Infect Dis; 2009 Sep; 32(5):453-61. PubMed ID: 18571235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus-Seronegative Recipients of the HSV529 Vaccine.
    Wang K; Dropulic L; Bozekowski J; Pietz HL; Jegaskanda S; Dowdell K; Vogel JS; Garabedian D; Oestreich M; Nguyen H; Ali MA; Lumbard K; Hunsberger S; Reifert J; Haynes WA; Sawyer JR; Shon JC; Daugherty PS; Cohen JI
    J Infect Dis; 2021 Nov; 224(9):1509-1519. PubMed ID: 33718970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.